Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Current Opinion in Pharmacology
|
July 2, 2013
Imaging mass spectrometry: challenges in visualization of drug distribution in solid tumors
Lavinia Morosi, Massimo Zucchetti, Maurizio D'Incalci, et al.
Frontiers in Oncology
|
October 9, 2013
Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents
Marta Cesca, Francesca Bizzaro, Massimo Zucchetti, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 20, 2004
Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry
Cristina Sottani, Massimo Zucchetti, Marco Zaffaroni, et al.
Mass Spectrometry Reviews
|
June 6, 2020
THE SPACE DIMENSION AT THE MICRO LEVEL: MASS SPECTROMETRY IMAGING OF DRUGS IN TISSUES
Enrico Davoli, Massimo Zucchetti, Cristina Matteo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 13, 2009
Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
Elena Marangon, Cristiano Falcioni, Carla Manzotti, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 26, 2009
Determination of total and lactone form of a new camptothecin derivative gimatecan (ST1481) and its metabolite ST1698 in human plasma by high-performance liquid chromatography with fluorimetric detection
Silvia Pace, Francesca Capocasa, Carlo Tallarico, et al.
Therapeutic Drug Monitoring
|
December 18, 2013
Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginase
Claudia Lanvers-Kaminsky, Petra Schulze Westhoff, Maurizio DʼIncalci, et al.
Journal of Mass Spectrometry : JMS
|
October 18, 2007
Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry
Elena Marangon, Federica Sala, Orazio Caffo, et al.
Journal of Mass Spectrometry : JMS
|
October 21, 2011
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study
Federica Sala, Renzo Bagnati, Valeria Livi, et al.
Journal of Mass Spectrometry : JMS
|
September 28, 2010
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study
Federica Sala, Elena Marangon, Renzo Bagnati, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Current Opinion in Pharmacology
|
July 2, 2013
Imaging mass spectrometry: challenges in visualization of drug distribution in solid tumors
Lavinia Morosi, Massimo Zucchetti, Maurizio D'Incalci, et al.
Frontiers in Oncology
|
October 9, 2013
Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents
Marta Cesca, Francesca Bizzaro, Massimo Zucchetti, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 20, 2004
Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry
Cristina Sottani, Massimo Zucchetti, Marco Zaffaroni, et al.
Mass Spectrometry Reviews
|
June 6, 2020
THE SPACE DIMENSION AT THE MICRO LEVEL: MASS SPECTROMETRY IMAGING OF DRUGS IN TISSUES
Enrico Davoli, Massimo Zucchetti, Cristina Matteo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 13, 2009
Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
Elena Marangon, Cristiano Falcioni, Carla Manzotti, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 26, 2009
Determination of total and lactone form of a new camptothecin derivative gimatecan (ST1481) and its metabolite ST1698 in human plasma by high-performance liquid chromatography with fluorimetric detection
Silvia Pace, Francesca Capocasa, Carlo Tallarico, et al.
Therapeutic Drug Monitoring
|
December 18, 2013
Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginase
Claudia Lanvers-Kaminsky, Petra Schulze Westhoff, Maurizio DʼIncalci, et al.
Journal of Mass Spectrometry : JMS
|
October 18, 2007
Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry
Elena Marangon, Federica Sala, Orazio Caffo, et al.
Journal of Mass Spectrometry : JMS
|
October 21, 2011
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study
Federica Sala, Renzo Bagnati, Valeria Livi, et al.
Journal of Mass Spectrometry : JMS
|
September 28, 2010
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study
Federica Sala, Elena Marangon, Renzo Bagnati, et al.
Page
of 10